Friday 6 November 2026 Export ONC’s income statement to Excel — free account

BeOne Medicines Ltd. - Sponsored ADR

BeOne Medicines Ltd. - Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $5.3 billion, up 40.2% from fiscal 2024.

Revenue: +33.8%
EPS: +143.7%
Free cash flow: +33.6%
Total debt: +491.3%

Quarter to September 2026, against a year earlier

407.60 20.35 +5.26%

Follow ONC

Alert me

Market cap: $40.4B
P/E: 65.9×
Fwd P/E: 48.8×
Dividend yield: —
F-score: 7/9
Altman Z: 5.25
Beneish M: −2.73
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

BeOne Medicines Ltd. - Sponsored ADR (ONC) revenue by segment, product and region

Where the money comes from and where it goes

Fiscal 2025: revenue by products and services, and margins
Product revenue, net	5,282	98.86%
Other Revenue	61	1.14%
Gross margin		87.49%
Operating margin		8.37%
Pre-tax margin		7.80%

Revenue by product or service $m

Line	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2018	FY2017
Product revenue, net	5,282 98.86%	3,780 99.19%	2,190 89.06%	1,255 88.61%	634 53.90%	309 100.00%	131 66.03%	24 10.25%
License	—	—	—	—	—	0 0.00%	—	—
Right To Access Intellectual Property Revenue	—	—	—	—	—	0 0.00%	—	—
Collaboration Reimbursement Of Research And Development Costs	—	—	—	—	—	—	57 28.64%	0 0.00%
Collaboration Research And Development Service	—	—	—	—	—	—	11 5.33%	3 1.08%
Collaboration Other	—	—	—	—	—	—	0 0.00%	0 0.00%
License Revenue	—	—	—	—	—	—	—	211 88.68%
Other Revenue	—	—	—	—	—	—	67	214
Revenue	5,343	3,810	2,459	1,416	1,176	309	198	238

Gross profit by product or service $m, and margin

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2018	FY2017
Product revenue, net	‡	‡	‡	‡	‡	‡	‡	‡
Gross profit	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡

Revenue by region $m

Line	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015
U.S. - total revenue	2,880 53.91%	1,957 51.37%	1,128 45.89%	503 35.50%	495 42.10%	18 5.90%	135 31.45%	43 21.59%	138 58.07%	0 0.00%	—
China	1,680 31.43%	1,411 37.04%	1,102 44.82%	840 59.33%	517 43.96%	291 94.10%	222 51.74%	132 66.79%	24 10.25%	0 0.00%	—
Europe - total revenue	611 11.44%	363 9.52%	202 8.22%	63 4.47%	163 13.86%	—	—	—	—	—	—
Rest of world - total revenue	172 3.22%	79 2.07%	27 1.08%	10 0.71%	1 0.07%	0 0.00%	72 16.81%	23 11.62%	76 31.69%	1 100.00%	9 100.00%
Revenue	5,343	3,810	2,459	1,416	1,176	309	428	198	238	1	9

As each company reports them in its 10-K and 10-Q filings, in US dollars. Where a later filing recast a year's segments, the year is shown as recast; a period whose breakdown does not add up to the company's revenue is left out.